Analyst opinions: changes for Air Liquide, Safran, Danone...
Price targets have mostly moved upward for Capgemini, Air Liquide and OVH, while Pluxee, STMicroelectronics and Melexis have seen several targets lowered. The most pronounced moves concern OVH, Avantium and Adyen.
Above their target price: 7 stocks · SBF 120 stocks covered: 120
Stocks trading above their target price: Teleperformance (-17.7%) · Eurofins Scientific (-16.5%) · bioMérieux (-12.3%) · Rémy Cointreau (-6.7%) · Dassault Systèmes (-3.0%) · Euronext (-1.7%) · Getlink (-0.4%)
Air Liquide: Berenberg remains at “buy” and raises its target from 205 to 210 euros; UBS, also at “buy,” raises its target from 200 to 204 euros. The median target stands at 196.50 euros, for a target-to-price gap of +8.7%.
From 95 to 85 euros at Saint-Gobain: Berenberg lowers its target while remaining at “buy.” 4 analysts had lowered their targets over the past 10 days, the latest move dating from October 29. Median at 95 euros, target-to-price gap: +38.3%.
Eight brokers are moving on Capgemini: Berenberg (“hold”) moves from 112 to 130 euros, Barclays from 130 to 145 euros, Morgan Stanley (“equal-weight”) from 117 to 119 euros, Oddo BHF (“outperform”) from 147 to 161 euros, Jefferies (“hold”) from 110 to 135 euros, Goldman Sachs (“buy”) from 150 to 170 euros, and Deutsche Bank, still at “buy,” from 150 to 151.80 euros. Invest Securities, at “buy,” shows 204 euros. The median target stands at 151.80 euros; target-to-price gap: +19.3%.
At Technip Energies, targets diverge: Berenberg (confirmed “buy”) raises its target from 40 to 42 euros, UBS (“buy”) from 39 to 40 euros, Goldman Sachs (“buy”) from 35 to 37 euros, while Oddo BHF (“outperform”) lowers its own from 45 to 44 euros. Median at 39.50 euros, target-to-price gap: +16.5%.
Mersen: still at “buy,” Berenberg adjusts its target from 50 to 51 euros. One analyst had raised its target on October 29. Median at 51 euros, target-to-price gap: +28.5%.
From 14 to 16 euros for EDP Renováveis: Intermoney, which remains at “buy,” raises its target. One analyst had lowered its target on October 27. The median target, at 16 euros, reflects a target-to-price gap of +28.3%.
Six brokers on Jeronimo Martins: Alphavalue moves from 25.60 to 26 euros, JP Morgan from 20.60 to 21.40 euros, BofA from 23 to 21.40 euros, and UBS Investment Bank from 27.50 to 27 euros, all at “buy.” AS Independent Research (“buy”) keeps 20.10 euros and Ipopema (“buy”) 22 euros. One analyst had lowered its target on October 23. Median at 21.30 euros, target-to-price gap: +14.9%.
Eramet: Alphavalue shows a “buy” rating with a target lowered from 55.50 to 54.20 euros. The median target is 48.50 euros; target-to-price gap: +29.4%.
A jump from 10 to 17 euros at OVH: JP Morgan remains at “overweight” and sharply raises its target. One analyst had raised its target on October 26. Median at 17 euros, target-to-price gap: +27.1%.
Four targets lowered on Pluxee: JP Morgan (“neutral”) from 17.50 to 15 euros, Morgan Stanley (“equal-weight”) from 15 to 12.50 euros, Oddo BHF (“neutral”) from 14 to 12.50 euros, and Deutsche Bank (“hold”) from 15 to 12.70 euros. Median at 12.70 euros, target-to-price gap: +7.3%.
Ackermans & van Haaren: ABN AMRO - ODDO BHF remains at “hold” and lowers its target from 300 to 292 euros. At ABN AMRO Oddo, the rating is “hold” with a target of 292 euros. Median at 305 euros, target-to-price gap: +14.7%.
Two cuts at STMicroelectronics: Kepler Cheuvreux, still at “buy,” moves from 78 to 70 euros, and Deutsche Bank, also at “buy,” from 70 to 65 euros. The median target, at 70 euros, leaves a target-to-price gap of +65.8%.
Stellantis: Kepler Cheuvreux, which remains at “hold,” adjusts its target from 4 to 4.50 euros. 3 analysts had lowered their targets over the past 10 days, the latest on October 29. Median at 4.50 euros, target-to-price gap: +9.3%.
From 110 to 115 euros at Alten: Kepler Cheuvreux raises its target while confirming its “buy.” One analyst had raised its target on October 28. Median at 115 euros, target-to-price gap: +30.7%.
Rémy Cointreau: Kepler Cheuvreux remains at “buy” and raises its target from 55 to 59 euros. 5 analysts had raised their targets over the past 10 days, the latest on October 29. The median target, at 48.50 euros, sits below the share price: target-to-price gap: -6.7%.
At Imerys, Kepler Cheuvreux (confirmed “buy”) moves from 28.40 to 29 euros, and BNP Paribas Exane (“neutral”) from 23 to 24 euros. Median at 25 euros, i.e. a target-to-price gap of zero (0%).
From 49 to 20 euros: Stifel’s target on Avantium is cut by more than half, the rating remaining at “buy.” Median at 4.02 euros, target-to-price gap: +69.6%.
Danone: BofA Securities, which remains at “buy,” raises its target from 92 to 93 euros, while Jefferies is at “hold” with a target of 60 euros. One analyst had raised its target on October 29. Median at 82 euros, target-to-price gap: +24.2%.
At Dassault Systèmes, BofA Securities (confirmed “hold”) moves from 26 to 27 euros; Barclays’ move drives the target from 21 to 23 euros. 5 analysts had raised their targets and 1 had lowered it over the past 10 days. Median at 24.50 euros, below the share price: target-to-price gap: -3%.
From 64 to 60 euros at SPIE: the move comes from BofA Securities. Median at 57 euros, target-to-price gap: +29.1%.
Elis: BofA Securities remains at “hold” and lowers its target from 27 to 26 euros. Median at 29.20 euros, target-to-price gap: +24.8%.
Three brokers on Sopra Steria: BofA Securities (“hold”) from 210 to 213 euros, UBS (“sell”) from 156 to 160 euros, and Invest Securities (“buy”) from 232 to 230 euros. Median at 216 euros, target-to-price gap: +12.1%.
From 1,600 to 1,400 euros at Adyen: ING Wholesale lowers its target while remaining at “buy.” 4 analysts had lowered their targets over the past 10 days, the latest on October 29. Median at 1,200 euros, target-to-price gap: +44.8%.
Two targets lowered on Melexis: ING Wholesale moves from 75 to 60 euros and Deutsche Bank from 75 to 65 euros, both remaining at “hold.” One analyst had lowered its target on October 28. Median at 65 euros, target-to-price gap: +17.3%.
TotalEnergies: UBS remains at “buy” and raises its target from 89 to 93 euros; CIC Market Solutions, at “buy,” keeps 106.70 euros. Median at 89 euros, target-to-price gap: +4.9%.
At Amundi, UBS (“buy”) moves from 105 to 106 euros, Mediobanca (“neutral”) from 90 to 95 euros, and Barclays’ move drives the target from 90 to 94 euros. Median at 98 euros, target-to-price gap: +6.5%.
From 83 to 90 euros at Sanofi: the move comes from Barclays. CIC Market Solutions, at “buy,” remains at 92 euros. Median at 88.50 euros, target-to-price gap: +11.2%.
Accor: Barclays is at “hold,” with a target lowered from 55 to 51 euros. One analyst had raised its target on October 26. Median at 53 euros, target-to-price gap: +12.3%.
At SCBSM, Invest Securities shows a “buy” rating with a target of 11.30 euros.
Guillemot: Invest Securities remains at “buy” and lowers its target from 5.70 to 5.30 euros. Target-to-price gap: +38% (median at 5.30 euros).
From 8.70 to 8.40 euros at ABL Diagnostics: Invest Securities adjusts its target, the rating remaining at “buy.” Median at 8.70 euros, target-to-price gap: +268.6%.
AXA: CIC Market Solutions, at “buy,” maintains 50 euros; Grupo Santander is at “outperform” with a target of 51.70 euros. Median at 51 euros, target-to-price gap: +19.4%.
At Crédit Agricole S.A., CIC Market Solutions (“buy”) keeps 22 euros while Morgan Stanley (“market weight”) moves from 21 to 19 euros. Median at 20.90 euros, target-to-price gap: +39.5%.
Citi is at “buy” on Vusion, with a target of 250 euros. Median at 235 euros, target-to-price gap: +64.9%.
Bureau Veritas: Citi, at “buy,” raises its target from 31.54 to 33.91 euros. One analyst had raised its target on October 27. Median at 34 euros, target-to-price gap: +15.6%.
Two upgrades on Eurofins Scientific: Citi (“neutral”) from 73.70 to 87.50 euros and Morgan Stanley (“underweight”) from 64.50 to 65.50 euros. 2 analysts had raised their targets over the past 10 days, the latest on October 26. The median, at 73.90 euros, sits below the share price: target-to-price gap: -16.5%.
From 32 to 28 euros for Vastned: Kempen, rating “neutral,” lowers its target. Median at 30.50 euros, target-to-price gap: +11.7%.
At Safran, Wells Fargo (“overweight”) lowers its target from 390 to 330 euros, and DZ Bank (“buy”) shows 339 euros. 13 analysts had lowered their targets over the past 10 days, the latest on October 28. Median at 350 euros, target-to-price gap: +25.2%.
Onward Medical: KBC Securities, at “buy,” lowers its target from 8.10 to 6 euros. Median at 9.40 euros, target-to-price gap: +349.8%.
From 76 to 78 euros at Montea: KBC Securities moves from “accumulate” to “buy” and raises its target. Median at 76.50 euros, target-to-price gap: +15.2%.
Eutelsat: Oddo BHF, at “neutral,” raises its target from 1.70 to 2 euros. One analyst had lowered its target on October 26. Median at 2 euros, target-to-price gap: +7.1%.
At Forvia, Oddo BHF is at “neutral” with a target lowered from 13 to 11 euros. Median at 11.93 euros, target-to-price gap: +39.5%.
From 1.10 to 1.40 euro at Coil: Portzamparc, at “hold,” raises its target.
Wavestone: Portzamparc, at “buy,” raises its target from 40.40 to 44 euros. Median at 44 euros, target-to-price gap: +26.1%.
At Edenred, Deutsche Bank is at “buy” with a target lowered from 35 to 32 euros. One analyst had lowered its target on October 28. Median at 32.50 euros, target-to-price gap: +35.5%.
Exel Industries: Euroland Corporate remains at “buy” and lowers its target from 30 to 27 euros. One analyst had lowered its target on October 28. Median at 23 euros, target-to-price gap: +35.3%.
Euroland Corporate is at “buy” on Obiz, with a target of 3.70 euros. Median at 3.70 euros, target-to-price gap: +42.3%.
From 1.85 to 1.73 euro at Paulic Meunerie: Greensome Finance adjusts its target while remaining at “buy.” Target-to-price gap: +49.1% (median at 1.73 euro).
Equasens: Greensome Finance, at “buy,” maintains its target at 63.70 euros. Median at 49 euros, target-to-price gap: +79.2%.
At Société Générale, Keefe Bruyette & Woods shows a “market perform” rating with a target raised from 75 to 76 euros. Median at 86.50 euros, target-to-price gap: +41.2%.
Rubis: Bernstein is at “outperform,” with a target raised from 38.70 to 43.20 euros. Median at 43.20 euros, target-to-price gap: +23.5%.
From 420 to 455 euros at L'Oréal: CICC, at “outperform,” raises its target. 13 analysts had raised their targets over the past 10 days, the latest on October 26. Median at 450 euros, target-to-price gap: +2.7%.
